Literature DB >> 26892407

Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR.

Rashmee U Shah1, James A de Lemos2, Tracy Y Wang3, Anita Y Chen3, Laine Thomas3, Nadia R Sutton4, James C Fang5, Benjamin M Scirica6, Timothy D Henry7, Christopher B Granger3.   

Abstract

BACKGROUND: Many patients with acute myocardial infarction (AMI) and cardiogenic shock survive hospitalization; little is known about their subsequent prognosis.
OBJECTIVES: This study sought to evaluate the associations between cardiogenic shock and post-discharge mortality and all-cause hospitalization among hospital survivors.
METHODS: We included patients ≥65 years of age with AMI from the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) who survived hospitalization and linked these patients with Medicare claims data. We used proportional hazards models to test the association between cardiogenic shock and outcomes, adjusting for patient and hospital characteristics. Hazard ratios (HRs) are reported for early (1 to 60 days) and late (61 to 365 days) post-discharge time periods.
RESULTS: Among 112,668 AMI survivors, 5% had cardiogenic shock during hospitalization. The rate of death was significantly higher among patients with cardiogenic shock at 60 days (9.6% vs. 5.5%) and 1 year (22.4% vs. 16.7%). After accounting for baseline characteristics, the risk of death remained higher for cardiogenic shock patients in the first 60 days after discharge (adjusted HR: 1.62; 95% confidence interval [CI]: 1.46 to 1.80), but was similar to nonshock patients thereafter (adjusted HR: 1.08 for days 61 to 365; 95% CI: 1.00 to 1.18). The rate of all-cause hospitalization or death was significantly higher among shock patients at 60 days (33.9% vs. 24.9%) and 1 year (59.1% vs. 52.3%). After adjustment, the risk of this outcome was also clustered in the first 60 days (adjusted HR: 1.28; 95% CI: 1.21 to 1.35) and was similar thereafter (adjusted HR: 0.95 for days 61 to 365; 95% CI: 0.89 to 1.01).
CONCLUSIONS: Hospital survivors of AMI who had cardiogenic shock have a higher risk of death and/or hospitalization during the first year after discharge. The risk is time-dependent and is clustered in the early post-discharge period, after which the prognosis is similar in patients with and without cardiogenic shock.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cause of death; follow-up studies; heart failure; outcomes assessment; patient readmission; prognosis

Mesh:

Year:  2016        PMID: 26892407     DOI: 10.1016/j.jacc.2015.11.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  'Combat' Approach to Cardiogenic Shock.

Authors:  Alexander G Truesdell; Behnam Tehrani; Ramesh Singh; Shashank Desai; Patricia Saulino; Scott Barnett; Stephen Lavanier; Charles Murphy
Journal:  Interv Cardiol       Date:  2018-05

2.  Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction.

Authors:  Alexander C Fanaroff; Eric D Peterson; Anita Y Chen; Laine Thomas; Jacob A Doll; Christopher B Fordyce; L Kristin Newby; Ezra A Amsterdam; Mikhail N Kosiborod; James A de Lemos; Tracy Y Wang
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676

Review 3.  When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock.

Authors:  Giulia Masiero; Francesco Cardaioli; Giulio Rodinò; Giuseppe Tarantini
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 4.  Management of cardiogenic shock complicating myocardial infarction.

Authors:  Alexandre Mebazaa; Alain Combes; Sean van Diepen; Alexa Hollinger; Jaon N Katz; Giovanni Landoni; Ludhmila Abrahao Hajjar; Johan Lassus; Guillaume Lebreton; Gilles Montalescot; Jin Joo Park; Susanna Price; Alessandro Sionis; Demetris Yannopolos; Veli-Pekka Harjola; Bruno Levy; Holger Thiele
Journal:  Intensive Care Med       Date:  2018-05-16       Impact factor: 17.440

5.  Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock.

Authors:  Saraschandra Vallabhajosyula; Stephanie R Payne; Jacob C Jentzer; Lindsey R Sangaralingham; Kianoush Kashani; Nilay D Shah; Abhiram Prasad; Shannon M Dunlay
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-02-08

Review 6.  Acute mechanical circulatory support for cardiogenic shock: the "door to support" time.

Authors:  Michele L Esposito; Navin K Kapur
Journal:  F1000Res       Date:  2017-05-22

7.  Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock: Findings From the 2013-2014 National Readmissions Database.

Authors:  Ahmed N Mahmoud; Islam Y Elgendy; Mohammad K Mojadidi; Siddharth A Wayangankar; Anthony A Bavry; R David Anderson; Hani Jneid; Carl J Pepine
Journal:  J Am Heart Assoc       Date:  2018-03-23       Impact factor: 5.501

Review 8.  Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.

Authors:  Deepak Acharya
Journal:  Cardiol Rev       Date:  2018 Sep/Oct       Impact factor: 2.644

9.  Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial Infarction.

Authors:  Alexander C Fanaroff; Anita Y Chen; Laine E Thomas; Karen S Pieper; Kirk N Garratt; Eric D Peterson; L Kristin Newby; James A de Lemos; Mikhail N Kosiborod; Ezra A Amsterdam; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2018-05-25       Impact factor: 5.501

10.  Association Between Intensive Care Unit Usage and Long-Term Medication Adherence, Mortality, and Readmission Among Initially Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction.

Authors:  Alexander C Fanaroff; Anita Y Chen; Sean van Diepen; Eric D Peterson; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2020-03-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.